Study Proposal for Web Based Intervention to Promote the Safe Usage of Dating Applications in Young Adults
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03685643 |
|
Recruitment Status :
Completed
First Posted : September 26, 2018
Results First Posted : April 28, 2020
Last Update Posted : April 28, 2020
|
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Sex, Unsafe Adolescent Behavior Behavior, Sex | Behavioral: Intervention - Dating application topic Behavioral: Control - Health and exercise topic | Not Applicable |
Dating applications are a popular platform to meet new people; however, they have been associated with risks such as unsafe sexual behavior and privacy concerns in young adults.
The study design is an open-labeled cluster randomized controlled trial with an intervention and a placebo control arm. The intervention group will receive a web-based intervention developed through focus group discussions, crowdsourcing contest, and a Peer-Vetted Creative Production (PVCP) workshop comprising of four short videos, a risk assessment tool, and a scenario game. The control group will receive a web-based resource with similar multimedia elements on health and exercise.
Based on the Information, Motivation, and Behavioral Skills (IMB) Model, the primary outcome of this study is self-efficacy in using dating applications measured by the General Self Efficacy Scale. Secondary outcomes include change in attitudes regarding risk perception measured by the Risk Propensity Scale and depression symptoms.
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 578 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | None (Open Label) |
| Primary Purpose: | Prevention |
| Official Title: | Study Protocol for a Peer-led Web-based Intervention to Promote Safe Usage of Dating Applications Amongst Young Adults: A Cluster Randomized Controlled Trial |
| Actual Study Start Date : | September 7, 2018 |
| Actual Primary Completion Date : | August 7, 2019 |
| Actual Study Completion Date : | August 7, 2019 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: Intervention - Dating application topic
The intervention will consist of four short videos with points of discussion, a scenario game, and a risk assessment tool regarding dating application usage.
|
Behavioral: Intervention - Dating application topic
The intervention will consist of multimedia content to promote the safe usage of dating applications and raise awareness of the risks associated with dating application usage. The intervention will be delivered one-time in a classroom setting. |
|
Placebo Comparator: Control - Health and exercise topic
The control will consist of four short videos with discussion points and an interaction game regarding exercise and healthy living tips.
|
Behavioral: Control - Health and exercise topic
The placebo control will consist of multimedia content regarding exercise and healthy living. It will be delivered once-time in a classroom setting. |
- Self Efficacy: This Will be Measured by the General Self Efficacy Scale [ Time Frame: 8 months ]The primary outcome will be the self-efficacy on the safe usage of dating. applications among young adults in Hong Kong. This will be measured by the General Self Efficacy Scale. The General Self Efficacy Scale is a 10-item scale (with 4 level Likert scale ranging from "not true at all" to "exactly true") measuring one's self-belief in completing certain tasks or overcoming difficulties. The total score is calculated by finding the sum of all items with the total score ranging between 10 and 40, with a higher score indicating a higher level of self efficacy.
- Risk Taking Tendencies Will be Measured by the The Risk Propensity Scale. [ Time Frame: 8 month ]Participants' risk taking tendencies will be measured by the The Risk Propensity Scale. It is a 9-item scale measuring general risk-taking tendencies. Each item is rated on a 9 level Likert scale (ranging from "totally disagree" to "totally agree") with the final score ranging from 1-9. A higher score indicates higher risk-taking tendencies.
- Depression Symptoms Will be Measured by the Patient Health Questionnaire-2 (PHQ-2). [ Time Frame: 8 month ]Participants' risk of depression will be measured by the Patient Health Questionnaire-2 (PHQ-2). This is a 2 item scale (with a 4 level Likert scale ranging from "Not at all" to "Nearly everyday") and the score ranges from 0-6, with a higher score indicating higher risk of depression.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 17 Years to 27 Years (Child, Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- 17-27 years old
- Able to read and understand Chinese
Exclusion Criteria:
- Have a physical impediment (e.g. blindness) to prevent them from accessing the content
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03685643
| Hong Kong | |
| Caritas Institute of Community Education | |
| Hong Kong, Hong Kong | |
| Vocational Training Council (VTC) | |
| Hong Kong, Hong Kong | |
| Principal Investigator: | William Wong | The University of Hong Kong |
Documents provided by The University of Hong Kong:
| Responsible Party: | The University of Hong Kong |
| ClinicalTrials.gov Identifier: | NCT03685643 |
| Other Study ID Numbers: |
09160275 HKUCTR-2512 ( Registry Identifier: HKU Clinical Trials Registry ) |
| First Posted: | September 26, 2018 Key Record Dates |
| Results First Posted: | April 28, 2020 |
| Last Update Posted: | April 28, 2020 |
| Last Verified: | April 2020 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | Yes |
| Plan Description: | The data will include baseline demographics, dating application usage and behavior, and the primary and secondary outcomes. |
| Supporting Materials: |
Study Protocol Informed Consent Form (ICF) |
| Time Frame: | Data will be available 6 months after study completion. |
| Access Criteria: | Data access requests will be reviewed by an external review panel. |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Peer-led, dating applications, young adults, sexual behavior |